CIBC Bancorp USA’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.91M Sell
220,897
-60,523
-22% -$1.02M ﹤0.01% 820
2026
Q2
$4.47M Sell
281,420
-67,472
-19% -$1.05M 0.01% 786
2026
Q1
$4.71M Buy
+348,892
New +$4.88M 0.01% 722
2025
Q3
$1.18M Buy
+119,047
New +$1.16M 0.01% 657

Other funds holding VTRS

CIBC Bancorp USA's VTRS Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Viatris (VTRS) stake by 22% in Q3 2026, selling an estimated $1.02M and leaving 220,897 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #820.

CIBC Bancorp USA first reported a position in VTRS in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.71M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • CIBC Bancorp USA held 220,897 shares of Viatris worth $3.91M as of Q3 2026.
  • CIBC Bancorp USA sold 60,523 Viatris shares in Q3 2026, an estimated $1.02M.
  • Viatris made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #820 holding.
  • CIBC Bancorp USA first reported a position in Viatris in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Viatris position peaked at $4.71M in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.